Research Articles
Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort
Anna Gottschlich, Dirk van Niekerk, Laurie W. Smith, Lovedeep Gondara, Joy Melnikow, Darrel A. Cook, Marette Lee, Gavin Stuart, Ruth E. Martin, Stuart Peacock, Eduardo L. Franco, Andrew Coldman, Mel Krajden and Gina Ogilvie
Anna Gottschlich
1Women's Health Research Institute, BC Women's Hospital and Health Service, Vancouver, British Columbia, Canada.
2Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Dirk van Niekerk
3Lower Mainland Laboratories, Vancouver, British Columbia, Canada.
4Cervical Cancer Screening Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Laurie W. Smith
1Women's Health Research Institute, BC Women's Hospital and Health Service, Vancouver, British Columbia, Canada.
4Cervical Cancer Screening Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Lovedeep Gondara
4Cervical Cancer Screening Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Joy Melnikow
5Center for Healthcare Policy and Research, University of California Davis, Sacramento, California.
Darrel A. Cook
4Cervical Cancer Screening Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
6British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Marette Lee
4Cervical Cancer Screening Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Gavin Stuart
2Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Ruth E. Martin
2Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Stuart Peacock
7Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
8Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, British Columbia, Canada.
9Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.
Eduardo L. Franco
10Division of Cancer Epidemiology, McGill University, Montreal, Quebec, Canada.
Andrew Coldman
4Cervical Cancer Screening Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Mel Krajden
2Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
6British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Gina Ogilvie
1Women's Health Research Institute, BC Women's Hospital and Health Service, Vancouver, British Columbia, Canada.
2Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
6British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
DOI: 10.1158/1055-9965.EPI-20-1177 Published January 2021

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
January 2021
Volume 30, Issue 1
Volume 30, Issue 1
Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort
Anna Gottschlich, Dirk van Niekerk, Laurie W. Smith, Lovedeep Gondara, Joy Melnikow, Darrel A. Cook, Marette Lee, Gavin Stuart, Ruth E. Martin, Stuart Peacock, Eduardo L. Franco, Andrew Coldman, Mel Krajden and Gina Ogilvie
Cancer Epidemiol Biomarkers Prev January 1 2021 (30) (1) 22-29; DOI: 10.1158/1055-9965.EPI-20-1177
Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort
Anna Gottschlich, Dirk van Niekerk, Laurie W. Smith, Lovedeep Gondara, Joy Melnikow, Darrel A. Cook, Marette Lee, Gavin Stuart, Ruth E. Martin, Stuart Peacock, Eduardo L. Franco, Andrew Coldman, Mel Krajden and Gina Ogilvie
Cancer Epidemiol Biomarkers Prev January 1 2021 (30) (1) 22-29; DOI: 10.1158/1055-9965.EPI-20-1177
Jump to section
Advertisement